USPSTF Issues Draft Recommendation for CRC Screening
Benefit substantial for adults aged 50 to 75 years; benefit moderate for adults aged 45 to 49 years.
Benefit substantial for adults aged 50 to 75 years; benefit moderate for adults aged 45 to 49 years.
Reminder + FIT reduced costs per additional Medicaid enrollee screened compared with reminder only.
During 2018, 548 low-dose lung screenings were performed at 104 sites; five lung cancers detected.
Annual CT screening recommended for those aged 50 to 80 years at high risk due to smoking history.
Early initiation of breast cancer screening with MRI may reduce breast cancer mortality by more than half.
Automated dual-stained slide evaluation reduces number of colposcopies versus current standards.
A new analysis looking at the effect of PSA screening on prostate cancer mortality over a 25-year period found a more favorable balance of benefits and harms than the 16-year estimates from the European Randomized Study of Screening for Prostate Cancer.
Women participating in mammography screening also had decrease in rate of advanced breast cancer.
Less intensive PSA screening in men with low PSA levels can substantially reduce unnecessary testing, according to investigators.
Risk-based screening yields less overdiagnosis, more cost-effective than age-based screening.